Thomas M Hallam

459 total citations
13 papers, 317 citations indexed

About

Thomas M Hallam is a scholar working on Immunology, Hematology and Nephrology. According to data from OpenAlex, Thomas M Hallam has authored 13 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 4 papers in Hematology and 3 papers in Nephrology. Recurrent topics in Thomas M Hallam's work include Complement system in diseases (11 papers), Retinal Diseases and Treatments (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Thomas M Hallam is often cited by papers focused on Complement system in diseases (11 papers), Retinal Diseases and Treatments (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Thomas M Hallam collaborates with scholars based in United Kingdom, United States and Australia. Thomas M Hallam's co-authors include Steven D. Schimmel, Candace L. Floyd, J. Paul Muizelaar, Michael Folkerts, Robert F. Berman, Bruce G. Lyeth, David Kavanagh, Claire L. Harris, Kevin J. Marchbank and Stephen J. Sharp and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Thomas M Hallam

12 papers receiving 302 citations

Peers

Countries citing papers authored by Thomas M Hallam

Since Specialization

Citations

This map shows the geographic impact of Thomas M Hallam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M Hallam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M Hallam more than expected).

Fields of papers citing papers by Thomas M Hallam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M Hallam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M Hallam. The network helps show where Thomas M Hallam may publish in the future.

Co-authorship network of co-authors of Thomas M Hallam

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M Hallam. A scholar is included among the top collaborators of Thomas M Hallam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M Hallam. Thomas M Hallam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Comprehensive functional characterization of complement factor I rare variant genotypes identified in the SCOPE geographic atrophy cohort 2024 ·Journal of Biological Chemistry ·Thomas M Hallam, (unknown), (unknown), Vicky Brocklebank, Emanuela Gardenal, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
2	The role of complement factor I rare genetic variants in age related macular degeneration in Finland 2024 ·Human Molecular Genetics ·(unknown), Thomas M Hallam, Vicky Brocklebank, (unknown), Patrick R. Walsh, Tom Southerington, Marco Hautalahti, David Steel, Andrew Lotery, Claire L. Harris, Kevin J. Marchbank, David Kavanagh, Amy V. Jones	0
3	Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study 2023 ·Blood ·Vicky Brocklebank, Patrick R. Walsh, (unknown), Thomas M Hallam, Kevin J. Marchbank, Valerie Wilson, Theophile Bigirumurame, Tina Dutt, (unknown), Michal Malina, (unknown), Sally Johnson, Neil Sheerin, David Kavanagh	22
4	Complement factor I: Regulatory nexus, driver of immunopathology, and therapeutic 2023 ·Immunobiology ·Thomas M Hallam, Stephen J. Sharp, Aikaterini Andreadi, David Kavanagh	24
5	A novel method for real-time analysis of the complement C3b:FH:FI complex reveals dominant negative CFI variants in age-related macular degeneration 2022 ·Frontiers in Immunology ·Thomas M Hallam, (unknown), (unknown), Vicky Brocklebank, (unknown), Nikolaos Tzoumas, David Steel, Edwin Wong, (unknown), Andrew Lotery, Claire L. Harris, Kevin J. Marchbank, David Kavanagh	6
6	Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway 2022 ·Immunological Reviews ·(unknown), Thomas M Hallam, Lawrence C. S. Tam, (unknown), Jane P. Hughes, Scott Ellis, Claire L. Harris	21
7	P791: COMMON VARIANTS IN COMPLEMENT PROTEINS, C3 AND CR1, ENHANCE COMPLEMENT ATTACK ON PNH ERYTHROCYTES AND INCREASE RISK FOR EXTRAVASCULAR HAEMOLYSIS 2022 ·HemaSphere ·(unknown), (unknown), R.J. Fellows, Thomas M Hallam, (unknown), (unknown), Suzanne H Richards, (unknown), Richard J. Kelly, Morag Griffin, Peter Hillmen, Kevin J. Marchbank, David Kavanagh, (unknown), C.J. Harris	1
8	Functional Characterization of Rare Genetic Variants in the N-Terminus of Complement Factor H in aHUS, C3G, and AMD 2021 ·Frontiers in Immunology ·Edwin Wong, Thomas M Hallam, Vicky Brocklebank, Patrick R. Walsh, (unknown), (unknown), (unknown), Holly E. Anderson, Paul N. Barlow, Kevin J. Marchbank, Claire L. Harris, David Kavanagh	14
9	Insights Into the Structure-Function Relationships of Dimeric C3d Fragments 2021 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), Liudmila Kulik, (unknown), Catherine R. Back, Thomas M Hallam, (unknown), (unknown), (unknown), Maisem Laabei, Alastair D. G. Lawson, V. Michael Holers, Andrew G. Watts, S.J. Crennell, Claire L. Harris, Kevin J. Marchbank, Jean van den Elsen	5
10	Homodimeric Minimal Factor H: In Vivo Tracking and Extended Dosing Studies in Factor H Deficient Mice 2021 ·Frontiers in Immunology ·(unknown), Talat H. Malik, Thomas M Hallam, (unknown), Yi Yang, (unknown), Saimir Luli, (unknown), (unknown), (unknown), (unknown), Isabel Y. Pappworth, Lei Huang, David Kavanagh, Matthew C. Pickering, Kevin J. Marchbank	9
11	Rare Genetic Variants in Complement Factor I Lead to Low FI Plasma Levels Resulting in Increased Risk of Age-Related Macular Degeneration 2020 ·Investigative Ophthalmology & Visual Science ·Thomas M Hallam, Kevin J. Marchbank, Claire L. Harris, Clive Osmond, (unknown), Helen Griffiths, Angela J. Cree, David Kavanagh, Andrew Lotery	38
12	Comparison of Behavioral Deficits and Acute Neuronal Degeneration in Rat Lateral Fluid Percussion and Weight-Drop Brain Injury Models 2004 ·Journal of Neurotrauma ·Thomas M Hallam, Candace L. Floyd, Michael Folkerts, (unknown), (unknown), Bruce G. Lyeth, J. Paul Muizelaar, Robert F. Berman	133
13	Rapid alteration in Ca++ content and fluxes in phorbol 12-myristate 13-acetate treated myoblasts 1980 ·Biochemical and Biophysical Research Communications ·Steven D. Schimmel, Thomas M Hallam	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact